Amneal Stock Performance


USD 2.10  0.01  0.48%   

The firm shows a Beta (market volatility) of 1.0017, which signifies a somewhat significant risk relative to the market. Let's try to break down what Amneal's beta means in this case. Amneal Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Amneal Pharmaceuticals is expected to follow. Even though it is essential to pay attention to Amneal Pharmaceuticals historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Amneal Pharmaceuticals exposes twenty-six different technical indicators, which can help you to evaluate its performance. Amneal Pharmaceuticals has an expected return of -0.66%. Please be advised to confirm Amneal Pharmaceuticals treynor ratio, as well as the relationship between the expected short fall and day median price to decide if Amneal Pharmaceuticals performance from the past will be repeated at some point in the near future.
Amneal Performance
0 of 100
Over the last 90 days Amneal Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in October 2022. The current disturbance may also be a sign of long term up-swing for the company investors. ...more

Amneal Price Channel

Quick Ratio1.30
Fifty Two Week Low2.0000
Target High Price8.00
Fifty Two Week High5.9900
Target Low Price4.50

Amneal Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  332.00  in Amneal Pharmaceuticals on July 2, 2022 and sell it today you would lose (124.00)  from holding Amneal Pharmaceuticals or give up 37.35% of portfolio value over 90 days. Amneal Pharmaceuticals is currently does not generate positive expected returns and assumes 4.0917% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Amneal, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Amneal Pharmaceuticals is expected to under-perform the market. In addition to that, the company is 3.6 times more volatile than its market benchmark. It trades about -0.16 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.08 per unit of volatility.

Amneal Pharmaceuticals Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Amneal Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Amneal Pharmaceuticals, and traders can use it to determine the average amount a Amneal Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1602

Good Returns
Average Returns
Small Returns
Negative ReturnsAMRX
Estimated Market Risk
  actual daily
 35 %
of total potential
Expected Return
  actual daily
 0 %
of total potential
Risk-Adjusted Return
  actual daily
 0 %
of total potential
Based on monthly moving average Amneal Pharmaceuticals is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Amneal Pharmaceuticals by adding it to a well-diversified portfolio.

About Amneal Pharmaceuticals Performance

To evaluate Amneal Pharmaceuticals Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Amneal Pharmaceuticals generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Amneal Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Amneal Pharmaceuticals market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Amneal's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. Amneal Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Bridgewater, New Jersey. Amneal Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 7000 people.

Things to note about Amneal Pharmaceuticals

Checking the ongoing alerts about Amneal Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Amneal Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.

Amneal Pharmaceuticals Alerts

Equity Alerts and Improvement Suggestions

Amneal Pharmaceuticals generated a negative expected return over the last 90 days
Amneal Pharmaceuticals has high historical volatility and very poor performance
About 68.0% of the company shares are held by institutions such as insurance companies
Latest headline from Institutional owners may take dramatic actions as Amneal Pharmaceuticals, Inc.s recent 11 percent drop adds to one-year losses - Simply Wall St
Please continue to Trending Equities. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for analysis

When running Amneal Pharmaceuticals price analysis, check to measure Amneal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals is operating at the current time. Most of Amneal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Amneal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
CEO Directory
Screen CEOs from public companies around the world
Transaction History
View history of all your transactions and understand their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Is Amneal Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amneal Pharmaceuticals. If investors know Amneal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amneal Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Amneal Pharmaceuticals is measured differently than its book value, which is the value of Amneal that is recorded on the company's balance sheet. Investors also form their own opinion of Amneal Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Amneal Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amneal Pharmaceuticals' market value can be influenced by many factors that don't directly affect Amneal Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amneal Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Amneal Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amneal Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.